二氧化碳衍生指标在脓毒症患者中的诊断与治疗价值研究进展
本文为综述,阐述脓毒症患者液体复苏中评估氧输送与氧需求的关键靶点,指出临床征象、血乳酸、混合静脉血氧饱和度(SvO2)或中心静脉血氧饱和度(ScvO2)均有局限性。近年来通过二氧化碳衍生指标如混合静脉-动脉二氧化碳分压差(Pv-aCO2、PCO2 gap或ΔPCO2)、混合静脉-动脉二氧化碳分压差与动脉-混合静脉氧含量差比值(Pv-aCO2/Ca-vO2)克服上述局限。Pv-aCO2并非纯无氧代谢指标,受氧耗影响,但可可靠反映血流是否足以将CO2从外周组织运送至肺清除,从而反映心输出量与代谢是否充分;Pv-aCO2/Ca-vO2可能作为缺氧标志物。脓毒症时即使氧输送充足,因微循环功能障碍等致组织氧利用下降,SvO2与ScvO2仍可降低。CO2在血浆中溶解度约为氧的20倍,故脓毒症或脓毒性休克时CO2衍生变量可能作为监测组织灌注与微循环血流动力学的敏感标志物,其主要优势是较血乳酸能快速变化并提供组织缺氧的实时监测。
要点
- Pv-aCO2(PCO2 gap或ΔPCO2)并非纯无氧代谢指标,受氧耗影响,但可可靠反映血流是否足以将CO2从外周组织运送至肺清除。
- Pv-aCO2/Ca-vO2可能作为缺氧标志物。
- 脓毒症时即使氧输送充足,因微循环功能障碍等致组织氧利用下降,SvO2与ScvO2仍可降低。
- CO2在血浆中溶解度约为氧的20倍,脓毒症或脓毒性休克时CO2衍生变量可能作为监测组织灌注与微循环血流动力学的敏感标志物。
- CO2衍生变量较血乳酸的主要优势是能快速变化并提供组织缺氧的实时监测。
适用人群与场景
- 脓毒症患者(包括脓毒性休克),用于液体复苏中评估氧输送与氧需求。
研究设计与关键结果
- 综述指出临床征象、血乳酸水平、SvO2或ScvO2在评估脓毒症液体复苏氧输送与氧需求时均有局限性。
- Pv-aCO2(PCO2 gap或ΔPCO2)并非纯无氧代谢指标,受氧耗影响,但可可靠反映血流是否足以将CO2从外周组织运送至肺清除,从而反映心输出量与代谢是否充分。
- Pv-aCO2/Ca-vO2可能作为缺氧标志物。
- SvO2与ScvO2反映组织氧利用;当氧输送下降而组织仍需更多氧时,氧摄取率通常增加以满足组织需求,导致SvO2与ScvO2降低;但在某些情况下,即使氧输送率与组织氧利用率降低,仍可导致SvO2与ScvO2降低。
- 脓毒症是典型例子:因微循环功能障碍等因素,即使氧输送充足,组织氧利用下降,导致SvO2与ScvO2降低。
- CO2在血浆中溶解度约为氧的20倍,故脓毒症或脓毒性休克时CO2衍生变量可能作为监测组织灌注与微循环血流动力学的敏感标志物。
- CO2衍生变量较血乳酸的主要优势是能快速变化并提供组织缺氧的实时监测。
证据类型、等级与局限
- 证据类型:综述。
- 局限:原文未报告局限性。
对床旁实践的改变
- 综述提示,在脓毒症或脓毒性休克中,CO2衍生变量(Pv-aCO2、Pv-aCO2/Ca-vO2)可能作为监测组织灌注与微循环血流动力学的敏感标志物,较血乳酸能快速变化并提供组织缺氧的实时监测。
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Effectively assessing oxygen delivery and demand is one of the key targets for fluid resuscitation in sepsis. Clinical signs and symptoms, blood lactic acid levels, and mixed venous oxygen saturation (SvO2) or central venous oxygen saturation (ScvO2) all have their limitations. In recent years, these limitations have been overcome through the use of derived indicators from carbon dioxide (CO2) such as mixed veno-arterial carbon dioxide partial pressure difference (Pv-aCO2, PCO2 gap, or ΔPCO2), the ratio of mixed veno-arterial carbon dioxide partial pressure difference to arterial-mixed venous oxygen content difference (Pv-aCO2/Ca-vO2). Pv-aCO2, PCO2 gap or ΔPCO2 is not a purely anaerobic metabolism indicator as it is influenced by oxygen consumption. However, it reliably indicates whether blood flow is sufficient to carry CO2 from peripheral tissues to the lungs for clearance, thus reflecting the adequacy of cardiac output and metabolism. The Pv-aCO2/Ca-vO2 may serve as a marker of hypoxia. SvO2 and ScvO2 represent venous oxygen saturation, reflecting tissue oxygen utilization. When oxygen delivery decreases but tissues still require more oxygen, oxygen extraction rate usually increases to meet tissue demands, resulting in decreased SvO2 and ScvO2. But in some cases, even if the oxygen delivery rate and tissue utilization rate of oxygen are reduced, it may still lead to a decrease in SvO2 and ScvO2. Sepsis is a classic example where tissue oxygen utilization decreases due to factors such as microcirculatory dysfunction, even when oxygen delivery is sufficient, leading to decrease in SvO2 and ScvO2. Additionally, the solubility of CO2 in plasma is approximately 20 times that of oxygen. Therefore, during sepsis or septic shock, derived variables of CO2 may serve as sensitive markers for monitoring tissue perfusion and microcirculatory hemodynamics. Its main advantage over blood lactic acid is its ability to rapidly change and provide real-time monitoring of tissue hypoxia. This review aims to demonstrate the principles of CO2-derived variables in sepsis, assess the available techniques for evaluating CO2-derived variables during the sepsis process, and discuss their clinical relevance.
参考来源
- Peng X, Zheng F, Zhu B, et al. [Research progress of diagnostic and therapeutic value of carbon dioxide-derived indicators in patients with sepsis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024. PMID: 38813642. doi:10.3760/cma.j.cn121430-20240122-00074
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。